Skip to content

CAPTIA CMV-G

by Mercia Diagnostics, Ltd.

510(k) K896194

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 5 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 5 Oct 2026. What this means

Regulatory status

as of registry sync 5 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK896194 Date6 Mar 1990ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 5 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Captia(R) Cmv-G
510(k) Number
FDA Product Code
LFZ
FDA applicant
Mercia Diagnostics , Ltd.
Device Class
Class II
Regulation
21 CFR Part 866.3175
Advisory Committee
Microbiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The CAPTIA CMV-G is an Enzyme Linked Immunoabsorbent Assay (ELISA) for the detection of cytomegalovirus (CMV) antibodies. This in vitro diagnostic device quantifies immunoglobulin G (IgG) antibodies to CMV, aiding in the serological diagnosis of CMV infection or immunity. It is classified under microbiological assays and designed for laboratory use to support clinical assessments of CMV exposure or disease status.

This device is supplied as a single-use reagent kit for professional laboratory use, requiring no special storage conditions beyond refrigeration. It is intended for use in clinical microbiology settings and has been granted FDA 510(k) clearance under product code LFZ, adhering to 21 CFR 866.3175. The assay is not MRI-compatible and must be handled in accordance with standard laboratory practices for immunoassays, ensuring sterility and accuracy in diagnostic results.

Other devices from Mercia Diagnostics, Ltd.

See all devices from Mercia Diagnostics, Ltd. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the CAPTIA CMV-G ELISA used for?

    The CAPTIA CMV-G ELISA is an in vitro diagnostic device designed to quantify immunoglobulin G (IgG) antibodies to cytomegalovirus (CMV). It aids in the serological diagnosis of CMV infection or immunity by providing quantitative results, helping clinicians assess a patient’s exposure or disease status related to CMV.

  • How is the CAPTIA CMV-G ELISA supplied and stored?

    The CAPTIA CMV-G ELISA is supplied as a single-use reagent kit intended for professional laboratory use. It requires standard refrigeration for storage, with no additional specialized conditions needed. Always follow standard laboratory practices to maintain sterility and accuracy.

  • Is the CAPTIA CMV-G ELISA intended for single-use or reuse?

    The CAPTIA CMV-G ELISA is explicitly designed for single-use only. This ensures sterility, consistency, and reliability in diagnostic results, as reuse could compromise the integrity of the assay and introduce contamination risks.

  • What are the key specifications or regulatory details for this device?

    The CAPTIA CMV-G ELISA has been granted FDA 510(k) clearance under product code LFZ, adhering to 21 CFR 866.3175. It is classified as an Enzyme Linked Immunoabsorbent Assay (ELISA) and falls under the microbiological assays category for clinical microbiology use. The device is not MRI-compatible and must be handled according to standard immunoassay laboratory protocols.

  • Can this device be used outside of a clinical microbiology lab?

    No, the CAPTIA CMV-G ELISA is specifically designed for laboratory use in clinical microbiology settings. Its intended use relies on controlled conditions, trained personnel, and proper equipment to ensure accurate and reliable diagnostic results for CMV antibody quantification.